Can we use existing guidance to support the development of robust real world evidence for health technology assessment/payer decision-making?

2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...

Read more →

NICE recommends NHS collects real world evidence on devices that monitor people with Parkinson’s disease

27 September 2022 - Five promising technologies that could help improve symptoms and quality of life for people with Parkinson’s disease ...

Read more →

The (harsh) reality of real-world data external comparators for health technology assessment

8 July 2022 - We read with great interest the recently published article by Patel et al. and commend the authors ...

Read more →

Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real world data: opportunities and challenges

25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials.  ...

Read more →

Aetion and NICE announce collaboration to explore use of real world evidence for comparative effectiveness studies to inform clinical guidance

6 October 2021 - Collaboration will leverage the Aetion Evidence Platform to study when and how real world evidence can support ...

Read more →

Do existing real world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal

28 April 2021 - Technological and computational advancements offer new tools for the collection and analysis of real world data.  ...

Read more →

NICE signs up to join the GetReal Institute

28 April 2021 -NICE’s ambition complements the GetReal Institute’s core mission to facilitate the adoption and implementation of real-world evidence ...

Read more →

Real world evidence to support payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

3 September 2020 - There are divergent views on the potential of real world data to inform decisions made by regulators, ...

Read more →

NICE partners with Flatiron Health to develop real world evidence research methodologies

14 July 2020 - Collaboration will help NICE expand use of real world data in service of better outcomes for UK ...

Read more →

Real world evidence use in assessments of cancer drugs by NICE

10 July 2020 - Single technology assessments published by NICE from April 2011 to October 2018 that evaluated cancer treatments were ...

Read more →

NICE explores extending its use of data to inform its guidance

25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...

Read more →

NICE explores extending its use of real world data to inform its guidance

25 June 2019 - NICE is looking to extend the use of real world data that will help inform its ...

Read more →

Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies

21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...

Read more →

Economic evaluation of personalised medicine: a call for real-world data

18 October 2017 - In the last decade, we have witnessed a change in healthcare management, with ‘personalised medicine’ as the ...

Read more →

Policies for use of real-world data in health technology assessment: a comparative study of six HTA agencies

11 April 2017 - Health technology assessment agencies worldwide are thus exploring whether real-world data may provide alternative sources of ...

Read more →